CellGENTherapies

CellGENTherapies is the GMP-unit of the University Hospital of Ghent Belgium. At CellGENTherapies, we specialize in the manufacturing of cell and gene therapies for early phase clinical trials. Our mission is to bring research “from bench to bedside” by offering academic and industry partners small-scale production of RNA vaccines and ATMPs for early clinical trials, for both off-the-shelf as well as for personalized medicine, in accordance with Good Manufacturing Practices (GMP). Next to manufacturing, we offer complementary high value services as IMPD writing, quality testing as well as technology transfer.